171 related articles for article (PubMed ID: 20840271)
1. Peroxisome proliferator-activated receptor-γ and -δ polymorphisms in women with polycystic ovary syndrome.
Christopoulos P; Mastorakos G; Gazouli M; Deligeoroglou E; Katsikis I; Diamanti-Kandarakis E; Panidis D; Creatsas G
Ann N Y Acad Sci; 2010 Sep; 1205():185-91. PubMed ID: 20840271
[TBL] [Abstract][Full Text] [Related]
2. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
[TBL] [Abstract][Full Text] [Related]
3. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.
Hahn S; Fingerhut A; Khomtsiv U; Khomtsiv L; Tan S; Quadbeck B; Herrmann BL; Knebel B; Müller-Wieland D; Mann K; Janssen OE
Clin Endocrinol (Oxf); 2005 May; 62(5):573-9. PubMed ID: 15853827
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of glucose metabolism and reproductive hormones in polycystic ovary syndrome on the basis of peroxisome proliferator-activated receptor (PPAR)-gamma2 Pro12Ala genotype.
Tok EC; Aktas A; Ertunc D; Erdal EM; Dilek S
Hum Reprod; 2005 Jun; 20(6):1590-5. PubMed ID: 15705622
[TBL] [Abstract][Full Text] [Related]
6. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study.
Lagou V; Scott RA; Manios Y; Chen TL; Wang G; Grammatikaki E; Kortsalioudaki C; Liarigkovinos T; Moschonis G; Roma-Giannikou E; Pitsiladis YP
Obesity (Silver Spring); 2008 Apr; 16(4):913-8. PubMed ID: 18379566
[TBL] [Abstract][Full Text] [Related]
7. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters.
Demirci H; Yilmaz M; Ergun MA; Yurtcu E; Bukan N; Ayvaz G
Gynecol Endocrinol; 2010 May; 26(5):348-55. PubMed ID: 20388053
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of insulin action in polycystic ovary syndrome.
Haap M; Machicao F; Stefan N; Thamer C; Tschritter O; Schnuck F; Wallwiener D; Stumvoll M; Häring HU; Fritsche A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):275-81. PubMed ID: 15926113
[TBL] [Abstract][Full Text] [Related]
9. Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome.
Orio F; Palomba S; Cascella T; Di Biase S; Labella D; Russo T; Savastano S; Zullo F; Colao A; Vettor R; Lombardi G
J Clin Endocrinol Metab; 2004 Oct; 89(10):5110-5. PubMed ID: 15472214
[TBL] [Abstract][Full Text] [Related]
10. Association of the T45G polymorphism in exon 2 of the adiponectin gene with polycystic ovary syndrome: role of Delta4-androstenedione.
Panidis D; Kourtis A; Kukuvitis A; Farmakiotis D; Xita N; Georgiou I; Tsatsoulis A
Hum Reprod; 2004 Aug; 19(8):1728-33. PubMed ID: 15178661
[TBL] [Abstract][Full Text] [Related]
11. Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 with decreased basic metabolic rate in women with polycystic ovary syndrome.
Koika V; Marioli DJ; Saltamavros AD; Vervita V; Koufogiannis KD; Adonakis G; Decavalas G; Georgopoulos NA
Eur J Endocrinol; 2009 Aug; 161(2):317-22. PubMed ID: 19465486
[TBL] [Abstract][Full Text] [Related]
12. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women.
Márquez JL; Pacheco A; Valdés P; Salazar LA
Clin Chim Acta; 2008 Dec; 398(1-2):5-9. PubMed ID: 18722363
[TBL] [Abstract][Full Text] [Related]
13. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.
Orio F; Matarese G; Di Biase S; Palomba S; Labella D; Sanna V; Savastano S; Zullo F; Colao A; Lombardi G
J Clin Endocrinol Metab; 2003 Dec; 88(12):5887-92. PubMed ID: 14671186
[TBL] [Abstract][Full Text] [Related]
14. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
15. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
Mlinar B; Ferk P; Pfeifer M; Geršak K; Marc J
Horm Metab Res; 2011 Jun; 43(6):427-32. PubMed ID: 21448847
[TBL] [Abstract][Full Text] [Related]
16. [Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome].
Jin L; Huang HF; Jin F; Qian YL
Zhonghua Fu Chan Ke Za Zhi; 2005 May; 40(5):323-6. PubMed ID: 15938783
[TBL] [Abstract][Full Text] [Related]
17. The relationship of the interleukin-6 -174 G>C gene polymorphism with cardiovascular risk factors in Turkish polycystic ovary syndrome patients.
Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Yilmaz C
Int J Immunogenet; 2009 Oct; 36(5):283-8. PubMed ID: 19744034
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in peroxisome proliferator-activated receptor gamma influence insulin resistance and testosterone levels in normal women, but not those with polycystic ovary syndrome.
Antoine HJ; Pall M; Trader BC; Chen YD; Azziz R; Goodarzi MO
Fertil Steril; 2007 Apr; 87(4):862-9. PubMed ID: 17141766
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-gamma and its coactivator-1alpha gene polymorphisms in Korean women with polycystic ovary syndrome.
Chae SJ; Kim JJ; Choi YM; Kim JM; Cho YM; Moon SY
Gynecol Obstet Invest; 2010; 70(1):1-7. PubMed ID: 20130411
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Pro12Ala polymorphism of the PPAR gamma 2 gene on response to pioglitazone treatment in menopausal women.
Ramírez-Salazar M; Pérez-Luque E; Fajardo-Araujo M; Garza SM; Malacara JM
Menopause; 2008; 15(6):1151-6. PubMed ID: 18551086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
